Anticipated Growth of the Pressure Ulcer Market by 2032: Key Players and Insights

The pressure ulcer market is poised for significant growth by 2032, with pivotal contributions from companies such as Phagelux, MiMedx, EyeGene, Shionogi, NovaLead Pharma, Smith & Nephew PLC, Integra LifeSciences, Baxter International, Molnlycke Health Care AB, Cardinal Health, Essity

Key Highlights from the Pressure Ulcer Market Report

  • Market Expansion: The pressure ulcer market is expected to grow significantly across the seven major markets (7MM) during the study period.
  • Increased Incidence Among Diabetic Patients: The prevalence of pressure ulcers is particularly high among individuals with diabetes. An estimated 537 million adults in the 7MM are living with diabetes, with around 150 million experiencing ulcers at some point.
  • U.S. Statistics: Studies suggest that approximately 10% of people in the United States will develop pressure ulcers at some stage in their lives.
  • Market Surge Drivers: The anticipated growth in the pressure ulcer market is driven by increasing prevalence rates, heightened awareness, and the introduction of innovative products within the pipeline.

Get a free sample of “Pressure Ulcer Market Report

Country-Specific Treatment Analysis

The report includes a detailed overview of treatment regimens across the 7MM, enabling companies to evaluate regional practices, patient journeys, and advancements in pressure ulcer therapies that have the potential to enhance treatment outcomes.

Understanding Pressure Ulcers

Pressure ulcers, commonly known as bedsores or pressure sores, are localized injuries to the skin and underlying tissues caused by prolonged pressure. These injuries often occur in individuals who are bedridden, use wheelchairs or have limited mobility, typically forming over bony areas such as the heels, hips, tailbone, and elbows. Factors influencing the development of pressure ulcers include pressure intensity, duration, and the individual's overall health. Insufficient blood flow to affected areas can lead to tissue damage, resulting in pain, open wounds, and severe complications, including infections.

Preventive measures for pressure ulcers include regular repositioning, maintaining proper nutrition, using specialized support surfaces, and ensuring effective skincare. Early detection and appropriate management are crucial for preventing ulcer progression and promoting healing. Healthcare professionals offer tailored treatments, including wound care, infection control, and pressure redistribution strategies, to manage pressure ulcers effectively.

Get a free sample of “Pressure Ulcer Market Report

Epidemiological Insights

The report provides historical and projected epidemiological insights, helping to illuminate the target patient population for pressure ulcers from 2019 to 2032. This analysis offers valuable information on patient trends that will shape market dynamics.

Epidemiology Segmentation Includes:

  • Total prevalence of pressure ulcers
  • Prevalent cases categorized by severity
  • Gender-specific prevalence rates
  • Diagnosed cases of episodic and chronic pressure ulcers

Emerging Therapies and Market Forecast

The report highlights notable emerging therapies, such as EGT 022 from EyeGene, a recombinant polypeptide derived from the human protein ADAM-15. Key developments in the market include:

  • Smith+Nephew’s Study: In March 2021, Smith+Nephew announced a real-world study indicating that switching to ALLEVYN LIFE Foam Dressings significantly reduced dressing change frequency and associated costs while enhancing treatment satisfaction among clinicians and patients.
  • CE Mark Approval: In February 2021, Axis Biosolutions received European CE mark approval for MAxiCel, an advanced wound care product effective for several chronic wounds, including pressure ulcers.

Research indicates that market dynamics are expected to evolve with the anticipated launch of new therapies, such as Thymosin Beta 4 and Ibuprofen, during the forecast period from 2019 to 2032. The growing prevalence of pressure ulcers and low competition for emerging therapies present stakeholders with significant market opportunities.

Strategic Insights for Stakeholders

DelveInsight's report equips stakeholders with crucial insights, market analyses, and forecasts essential for informed strategic decision-making. Key focus areas include:

  • Identifying Market Gaps: By analyzing epidemiological trends and existing treatment practices, stakeholders can identify unmet needs and explore opportunities for novel therapeutic developments.
  • Strategic Decision Making: Insights from market forecasts empower stakeholders to make informed choices regarding research and development investments, portfolio expansions, pricing strategies, and partnerships.
  • Roadmap to Success: The report helps leading companies set clear short- and long-term goals, define market penetration strategies, and navigate the complexities of the pressure ulcer market effectively.

About DelveInsight

DelveInsight is a leading healthcare business consulting and market research firm focused exclusively on life sciences. The company provides comprehensive end-to-end solutions aimed at enhancing the performance of pharmaceutical companies while also offering healthcare consulting services to facilitate market analysis, accelerate business growth, and address challenges with practical approaches.

Latest Reports

Prader-willi Syndrome Market | Progressive Supranuclear Palsy Market | Scleroderma Market | Vernal Keratoconjunctivitis Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Acute Pharyngitis Market | Acute Radiation Syndrome Market | Airway Stent Market Market | Alopecia Areata Market | Anti-cd274 Pd-l1 Antibody Pipeline | Apheresis Market | Artificial Lung Devices Market | Bacteremia Market | Biliary Tract Cancer Market | Bladder Pain Syndrome Market | Brain/cranial Implants Market | Capnography Device Market | Cardiac Amyloidosis Market | Catheter-related Bloodstream Infections Market | Cervical Intraepithelial Neoplasia Market | Chronic Obstructive Pulmonary Disease Market | Chronic Pruritus Market | Cluster Headache Market | Dermal Mycosis Market | Duchenne Muscular Dystrophy Market | Emesis Market | Foot And Ankle Devices Market | Gout Market | Graft Versus Host Disease Market | Head And Neck Cancer Market | Healthcare Competitive Intelligence


Steven William

23 Blog posts

Comments